198 related articles for article (PubMed ID: 23353804)
1. Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium.
Treister N; Chai X; Kurland B; Pavletic S; Weisdorf D; Pidala J; Palmer J; Martin P; Inamoto Y; Arora M; Flowers M; Jacobsohn D; Jagasia M; Arai S; Lee SJ; Cutler C
Bone Marrow Transplant; 2013 Aug; 48(8):1123-8. PubMed ID: 23353804
[TBL] [Abstract][Full Text] [Related]
2. Validation of the National Institutes of Health chronic GVHD Oral Mucosal Score using component-specific measures.
Bassim CW; Fassil H; Mays JW; Edwards D; Baird K; Steinberg SM; Williams KM; Cowen EW; Mitchell SA; Cole K; Taylor T; Avila D; Zhang D; Pulanic D; Grkovic L; Fowler D; Gress RE; Pavletic SZ
Bone Marrow Transplant; 2014 Jan; 49(1):116-21. PubMed ID: 23995099
[TBL] [Abstract][Full Text] [Related]
3. Oral chronic graft-vs.-host disease characterization using the NIH scale.
Fassil H; Bassim CW; Mays J; Edwards D; Baird K; Steinberg SM; Williams KM; Cowen EW; Mitchell SA; Hakim FT; Taylor T; Avila D; Zhang D; Grkovic L; Datiles M; Gress RE; Pavletic SZ
J Dent Res; 2012 Jul; 91(7 Suppl):45S-51S. PubMed ID: 22699667
[TBL] [Abstract][Full Text] [Related]
4. Validation of measurement scales in ocular graft-versus-host disease.
Inamoto Y; Chai X; Kurland BF; Cutler C; Flowers ME; Palmer JM; Carpenter PA; Heffernan MJ; Jacobsohn D; Jagasia MH; Pidala J; Khera N; Vogelsang GB; Weisdorf D; Martin PJ; Pavletic SZ; Lee SJ;
Ophthalmology; 2012 Mar; 119(3):487-93. PubMed ID: 22153706
[TBL] [Abstract][Full Text] [Related]
5. Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD).
Elad S; Zeevi I; Or R; Resnick IB; Dray L; Shapira MY
Biol Blood Marrow Transplant; 2010 Jan; 16(1):62-9. PubMed ID: 19733252
[TBL] [Abstract][Full Text] [Related]
6. Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.
Fall-Dickson JM; Mitchell SA; Marden S; Ramsay ES; Guadagnini JP; Wu T; St John L; Pavletic SZ;
Biol Blood Marrow Transplant; 2010 Jul; 16(7):948-956. PubMed ID: 20139026
[TBL] [Abstract][Full Text] [Related]
7. Oral chronic graft-versus-host disease scoring using the NIH consensus criteria.
Treister NS; Stevenson K; Kim H; Woo SB; Soiffer R; Cutler C
Biol Blood Marrow Transplant; 2010 Jan; 16(1):108-14. PubMed ID: 19772943
[TBL] [Abstract][Full Text] [Related]
8. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment].
Elad S; Levitt M; M Y S
Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):19-27, 72. PubMed ID: 19263864
[TBL] [Abstract][Full Text] [Related]
9. Oral Complications of Chronic Graft-Versus-Host Disease.
Fall-Dickson JM; Pavletic SZ; Mays JW; Schubert MM
J Natl Cancer Inst Monogr; 2019 Aug; 2019(53):. PubMed ID: 31425593
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.
Pidala J; Kurland B; Chai X; Majhail N; Weisdorf DJ; Pavletic S; Cutler C; Jacobsohn D; Palmer J; Arai S; Jagasia M; Lee SJ
Blood; 2011 Apr; 117(17):4651-7. PubMed ID: 21355084
[TBL] [Abstract][Full Text] [Related]
11. Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria.
Cuvelier GDE; Nemecek ER; Wahlstrom JT; Kitko CL; Lewis VA; Schechter T; Jacobsohn DA; Harris AC; Pulsipher MA; Bittencourt H; Choi SW; Caywood EH; Kasow KA; Bhatia M; Oshrine BR; Flower A; Chaudhury S; Coulter D; Chewning JH; Joyce M; Savaşan S; Pawlowska AB; Megason GC; Mitchell D; Cheerva AC; Lawitschka A; West LJ; Pan B; Al Hamarneh YN; Halevy A; Schultz KR
Blood; 2019 Jul; 134(3):304-316. PubMed ID: 31043425
[TBL] [Abstract][Full Text] [Related]
12. A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.
Mitchell SA; Jacobsohn D; Thormann Powers KE; Carpenter PA; Flowers ME; Cowen EW; Schubert M; Turner ML; Lee SJ; Martin P; Bishop MR; Baird K; Bolaños-Meade J; Boyd K; Fall-Dickson JM; Gerber LH; Guadagnini JP; Imanguli M; Krumlauf MC; Lawley L; Li L; Reeve BB; Clayton JA; Vogelsang GB; Pavletic SZ
Biol Blood Marrow Transplant; 2011 Nov; 17(11):1619-29. PubMed ID: 21536143
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease.
Baumrin E; Baker LX; Byrne M; Martin PJ; Flowers ME; Onstad L; El Jurdi N; Chen H; Beeghly-Fadiel A; Lee SJ; Tkaczyk ER
JAMA Dermatol; 2023 Apr; 159(4):393-402. PubMed ID: 36884224
[TBL] [Abstract][Full Text] [Related]
14. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria.
Sato T; Ichinohe T; Kanda J; Yamashita K; Kondo T; Ishikawa T; Uchiyama T; Takaori-Kondo A
Int J Hematol; 2011 Apr; 93(4):532-541. PubMed ID: 21465116
[TBL] [Abstract][Full Text] [Related]
16. Oral chronic GVHD outcomes and resource utilization: a subanalysis from the chronic GVHD consortium.
Yuan A; Chai X; Martins F; Arai S; Arora M; Correa ME; Pidala J; Cutler CS; Lee SJ; Treister NS
Oral Dis; 2016 Apr; 22(3):235-40. PubMed ID: 26708609
[TBL] [Abstract][Full Text] [Related]
17. National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution.
Lawitschka A; Gueclue ED; Januszko A; Körmöczi U; Rottal A; Fritsch G; Bauer D; Peters C; Greinix HT; Pickl WF; Kuzmina Z
Front Immunol; 2019; 10():1879. PubMed ID: 31507582
[TBL] [Abstract][Full Text] [Related]
18. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.
Herzberg PY; Heussner P; Mumm FH; Horak M; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix H; Freund M; Lee SJ; Holler E; Wolff D
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1707-17. PubMed ID: 20541028
[TBL] [Abstract][Full Text] [Related]
19. Oral involvement of chronic graft-versus-host disease in hematopoietic stem cell transplant recipients.
Noce CW; Gomes A; Copello A; Barbosa RD; Sant'anna S; Moreira MC; Correa ME; Maiolino A; Torres SR
Gen Dent; 2011; 59(6):458-62; quiz 463-4. PubMed ID: 22313917
[TBL] [Abstract][Full Text] [Related]
20. Clinical and histopathological features of the oral mucosa in allogeneic haematopoietic stem cell transplantation patients.
Demarosi F; Lodi G; Carrassi A; Moneghini L; Sarina B; Sardella A
Exp Oncol; 2007 Dec; 29(4):304-8. PubMed ID: 18199988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
